Stockscreener 앱 받기
1.70
0.00%
0.00
시간 외 거래:
1.68
-0.02
-1.18%
전일 마감가:
$1.70
열려 있는:
$1.72
하루 거래량:
921.89K
Relative Volume:
0.68
시가총액:
$144.49M
수익:
-
순이익/손실:
$-59.69M
주가수익비율:
-1.223
EPS:
-1.39
순현금흐름:
$-46.54M
1주 성능:
+9.68%
1개월 성능:
+7.59%
6개월 성능:
-23.08%
1년 성능:
+26.87%
1일 변동 폭
$1.67
$1.75
1주일 범위
$1.54
$1.75
52주 변동 폭
$0.6254
$2.75
Milestone Pharmaceuticals Inc Stock (MIST) Company Profile
명칭
Milestone Pharmaceuticals Inc
전화
(514) 336-0444
주소
1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420, MONTREAL, QC
MIST을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MIST
Milestone Pharmaceuticals Inc
|
1.70 | 144.44M | 0 | -59.69M | -46.54M | -1.39 |
|
VRTX
Vertex Pharmaceuticals Inc
|
389.88 | 100.71B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.87 | 58.84B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.91 | 61.52B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
661.32 | 40.01B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
319.32 | 38.20B | 3.81B | -644.79M | -669.77M | -6.24 |
Milestone Pharmaceuticals Inc Stock (MIST) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-06-05 | 재개 | H.C. Wainwright | Buy |
| 2024-08-22 | 개시 | Rodman & Renshaw | Buy |
| 2023-06-20 | 다운그레이드 | Jefferies | Buy → Hold |
| 2022-04-22 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2021-03-05 | 개시 | H.C. Wainwright | Buy |
| 2020-07-29 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2020-07-24 | 업그레이드 | Jefferies | Hold → Buy |
| 2020-03-25 | 다운그레이드 | Jefferies | Buy → Hold |
| 2020-03-24 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2020-03-24 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2019-06-04 | 개시 | Oppenheimer | Outperform |
| 2019-06-03 | 개시 | Cowen | Outperform |
| 2019-06-03 | 개시 | Jefferies | Buy |
| 2019-06-03 | 개시 | Piper Jaffray | Overweight |
모두보기
Milestone Pharmaceuticals Inc 주식(MIST)의 최신 뉴스
Milestone Pharmaceuticals Inc. Rebound Backed by Sentiment ShiftJuly 2025 Breakouts & Growth Focused Entry Point Reports - beatles.ru
Milestone Scientific to Report Q2 2025 Financial Results and Business Update - AInvest
Milestone Pharmaceuticals: Q2 Earnings Snapshot - Greenwich Time
Milestone Pharmaceuticals Reports Increased Loss Amid R&D Focus - TipRanks
Milestone Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Regulatory and Corporate Update - The Manila Times
Milestone Pharmaceuticals Announces FDA Acceptance of CARDAMYST™ CRL Response and Secures $170 Million in Public Offering - Quiver Quantitative
Milestone Pharmaceuticals Inc. SEC 10-Q Report - TradingView
Short Interest Drops in Milestone Pharmaceuticals Inc. After RallyCapital Protection Trading Strategies Gain Interest - metal.it
Arrowhead Pharmaceuticals, Inc. (ARWR) Secures $100M Milestone from Sarepta in RNAi Breakthrough Deal - MSN
Milestone Pharmaceuticals Inc expected to post a loss of 18 cents a shareEarnings Preview - TradingView
What drives Milestone Pharmaceuticals Inc. stock priceAchieve rapid portfolio growth with smart picks - Jammu Links News
What analysts say about Milestone Pharmaceuticals Inc. stockCapitalize on market momentum for maximum profit - Jammu Links News
Should I hold or sell Milestone Pharmaceuticals Inc. stock in 2025Consistently outstanding ROI - Jammu Links News
How many analysts rate Milestone Pharmaceuticals Inc. as a “Buy”Exponential return rates - Jammu Links News
Is Milestone Pharmaceuticals Inc. stock overvalued or undervaluedFree Daily Trading Room Entry - Jammu Links News
How volatile is Milestone Pharmaceuticals Inc. stock compared to the marketInvest confidently with actionable market data - Jammu Links News
What are the latest earnings results for Milestone Pharmaceuticals Inc.Capitalize on emerging trends for profits - Jammu Links News
What are analysts’ price targets for Milestone Pharmaceuticals Inc. in the next 12 monthsTrack high-yield stocks before they peak - Jammu Links News
What catalysts could drive Milestone Pharmaceuticals Inc. stock higher in 2025Invest confidently with advanced analysis tools - Jammu Links News
How does Milestone Pharmaceuticals Inc. compare to its industry peersMaximize your gains with professional insights - Jammu Links News
Stock Market News for Aug 1, 2025 - The Globe and Mail
Why Milestone Pharmaceuticals Inc. stock attracts strong analyst attentionConsistent Gain Investment Strategies Emerge - metal.it
Trading Bots Trigger Alerts on Milestone Pharmaceuticals Inc. ActivityReal Time Trade Opportunity Alerts Monitor Market Surges - metal.it
Can Milestone Pharmaceuticals Inc. hit a new high this monthSwing Setup With Technical Confirmation Explained - metal.it
RSI Suggests Rebound May Be Near in Milestone Pharmaceuticals Inc.Accurate Buy Point for Momentum Stocks Detected - metal.it
Published on: 2025-07-29 04:32:28 - beatles.ru
Arrowhead Pharmaceuticals Earns $100 Million Milestone from Sarepta Therapeutics - Business Wire
Is it the right time to buy Milestone Pharmaceuticals Inc. stockFree Capital Allocation Plans - Jammu Links News
What makes Milestone Pharmaceuticals Inc. stock price move sharplyMaximize profits with strategic stock selection - Jammu Links News
How Efficient Is Milestone Pharmaceuticals Inc. at Controlling Operating CostsFree Stock Selection - metal.it
Milestone Pharmaceuticals Inc (MIST) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.18%
자본화:
|
볼륨(24시간):